Your browser doesn't support javascript.
loading
Pulmonary Metastasectomy after Radiofrequency Ablation of Hepatocellular Carcinoma.
Osuga, Takahiro; Tanaka, Shingo; Kubo, Tomohiro; Hamaguchi, Kota; Ito, Ryo; Sakurada, Akira; Ishikawa, Keidai; Miyanishi, Koji.
Afiliación
  • Osuga T; Department of Medical Oncology, Sapporo Medical University School of Medicine, Hokkaido, Japan.
  • Tanaka S; Department of Medical Oncology, Sapporo Medical University School of Medicine, Hokkaido, Japan.
  • Kubo T; Department of Infection Control and Laboratory Medicine, Sapporo Medical University School of Medicine, Hokkaido, Japan.
  • Hamaguchi K; Department of Medical Oncology, Sapporo Medical University School of Medicine, Hokkaido, Japan.
  • Ito R; Department of Medical Oncology, Sapporo Medical University School of Medicine, Hokkaido, Japan.
  • Sakurada A; Department of Medical Oncology, Sapporo Medical University School of Medicine, Hokkaido, Japan.
  • Ishikawa K; Gastroenterology, Otaru Ekisaikai Hospital, Hokkaido, Japan.
  • Miyanishi K; Thoracic surgery, Otaru Kyokai Hospital, Hokkaido, Japan.
Case Rep Oncol ; 17(1): 407-416, 2024.
Article en En | MEDLINE | ID: mdl-38435446
ABSTRACT

Introduction:

Single distant metastases after radiofrequency ablation (RFA) of hepatocellular carcinoma (HCC) are rare. There are no guidelines for treating patients without liver tumors after resecting lung metastases. Case Presentation Here, we report a patient with HCC recurring as a single lung metastasis 14 months after RFA. A 76-year-old woman with primary biliary cholangitis without hepatitis B virus or hepatitis C virus infection had been treated by RFA for a single 16-mm-sized HCC lesion in liver S8. Fourteen months thereafter, despite lack of intrahepatic recurrence, a single new 26-mm-sized mass was found in S10 of the right lung. The patient underwent right lower lobectomy. The histopathological diagnosis was HCC metastasis. Because no residual disease could be found, she was followed up without any additional treatment after surgery. She remains alive with no signs of recurrence 3 years later.

Conclusion:

HCC patients who relapse with lung metastases but without intrahepatic recurrence after RFA are extremely rare, especially when RFA is used to treat HCC lesions <30 mm. However, it should be noted that, although rare, HCC may recur in the form of extrahepatic metastases after RFA. Furthermore, it is suggested that, as in the presently-described case, at least some patients without intrahepatic recurrence whose lung metastases are completely resected have a good prognosis even without additional treatment for HCC.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Case Rep Oncol Año: 2024 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Case Rep Oncol Año: 2024 Tipo del documento: Article País de afiliación: Japón